Tanguy Lechertier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tanguy Lechertier

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Plos One|October 12, 2012

Gene expression analysis in human breast cancer associated blood vesselsDylan T Jones, Tanguy Lechertier, Richard Mitter, et al.

Journal of Cell Science|April 8, 2017

Multiple roles of integrin-α3 at the neuromuscular junctionJacob A Ross, Richard G Webster, Tanguy Lechertier, et al.

Nature Communications|June 27, 2013

FAK-heterozygous mice display enhanced tumour angiogenesisVassiliki Kostourou, Tanguy Lechertier, Louise E Reynolds, et al.

Nature|August 1, 2014

Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapyBernardo Tavora, Louise E Reynolds, Silvia Batista, et al.

Nature Communications|June 6, 2020

Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growthTanguy Lechertier, Louise E Reynolds, Hyojin Kim, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016

A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in NeuroblastomaMaria Dvorkina, Valentina Nieddu, Shalini Chakelam, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Plos One|October 12, 2012

Gene expression analysis in human breast cancer associated blood vesselsDylan T Jones, Tanguy Lechertier, Richard Mitter, et al.

Journal of Cell Science|April 8, 2017

Multiple roles of integrin-α3 at the neuromuscular junctionJacob A Ross, Richard G Webster, Tanguy Lechertier, et al.

Nature Communications|June 27, 2013

FAK-heterozygous mice display enhanced tumour angiogenesisVassiliki Kostourou, Tanguy Lechertier, Louise E Reynolds, et al.

Nature|August 1, 2014

Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapyBernardo Tavora, Louise E Reynolds, Silvia Batista, et al.

Nature Communications|June 6, 2020

Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growthTanguy Lechertier, Louise E Reynolds, Hyojin Kim, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016

A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in NeuroblastomaMaria Dvorkina, Valentina Nieddu, Shalini Chakelam, et al.

Pageof 2